focus -WSS

focus

author：focus 2025-09-28 00:51:27 - browse：2

Hyundai Kia Recall — FILE - A line of 2022 Santa Fe SUV's sit outside a Hyundai dealership Sunday, Sept. 12, 2021, in Littleton, Colo. In documents posted Thursday, Aug. 3, 2023, Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires. (AP Photo/David Zalubowski, File)The Associated Press

DETROIT -- Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires.

The affiliated Korean automakers are recalling the vehicles and also are telling owners to park them away from structures until repairs are made.

The recalls cover certain 2023 and 2024 Hyundai Palisades, as well some 2023 Tucson, Sonata, Elantra and Kona vehicles. Affected Kias include the 2023 Soul and Sportage as well as some 2023 and 2024 Seltos vehicles.

The companies say in documents posted Thursday by U.S. safety regulators that a capacitor on a circuit board in the oil pump assembly for the transmission may have been damaged by the supplier during manufacturing. That can cause a short-circuit and increase the risk of a fire.

Kia says it has six reports of melting components but no fires or injuries. Hyundai says it has confirmed four “thermal incidents” and no injuries.

Dealers will inspect and replace the oil pump controller if necessary. Hyundai owners will be notified by letter on Sept. 25. Kia will notify owners starting Sept. 28.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA approves world's first CRISPR

WSS

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

What PEPFAR has meant on the ground in Ukraine

Teach medical students about patients with intellectual disabilities

SCOTUS to consider access to abortion pill mifepristone

FDA needs staff influx to meet gene therapy needs, Marks says

Wikipedia

focus

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Eating disorder hotline's move to chatbot carried cost for volunteers

Anesthesiologist group: stop taking Ozempic before surgery

Chemotherapy shortages won’t get better under Biden’s latest plan

After affirmative action ruling, medical educators look to 'holistic review'

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The simple reason for the increase in autism diagnosis

Trump demands the U.S. pay no more for drugs than other countries … again

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

focus

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

ADA: All diabetes patients should be screened for liver condition

CMS should re

SCOTUS to consider access to abortion pill mifepristone

Illumina to lay off 10% of research and development team

Supreme Court rules employers must be more accommodating of religious observance

entertainment

entertainment

entertainment

knowledge